{"PMID": "33957365", "OWN": "NLM", "STAT": "Publisher", "LR": "20210506", "IS": "1873-264X (Electronic) 0731-7085 (Linking)", "VI": "201", "DP": "2021 Apr 28", "TI": "qNMR quantification of phenolic compounds in dry extract of Myrcia multiflora leaves and its antioxidant, anti-AGE, and enzymatic inhibition activities.", "PG": "114109", "LID": "S0731-7085(21)00220-X [pii] 10.1016/j.jpba.2021.114109 [doi]", "AB": "Myrcia multiflora (Lam.) DC. is often used in Brazilian folk medicine to control diabetes. Analysis using HPLC-HRMS and NMR of the dry extract from the infusion of leaves of this species revealed twelve phenolic compounds. Among these compounds, chlorogenic acid (1), 4-O-caffeoylquinic acid (2), corilagin (3), chebulagic acid (4), pedunculagin (5), quercetin-3-O-beta-2''-galloylglucoside (7), and kaempferol-3-O-rhamnoside (12) are described for the first time in this matrix. Furthermore, six compounds were quantified using qNMR. The compounds in the dry extracts are 3, 6 (myricetin-3-O-d-glucoside), 8 (myricitrin), 9 (hyperoside), 10 (guaijaverin) and 11 (quercitrin). These compounds may be considered chemical markers in this matrix. In addition, this extract presents activities of alpha-glucosidase inhibition (IC50 = 79.9 mug mL(-1)) and glycation in vitro (IC50 = 10.2 mug mL(-1)), in addition to antioxidant activity against DPPH and ABTS radicals (1,856.7 and 1,032.0 mumol TEq, respectively). This extract did not show significant cytotoxicity in human fibroblasts. Therefore, the enzymatic inhibition, anti-AGE (advanced glycation end-products) and antioxidant activities of Myrcia multiflora leaves corroborated its antidiabetic therapeutic potential and instigates future preclinical studies aimed at the treatment of diabetes mellitus and its complications.", "CI": ["Copyright (c) 2021 Elsevier B.V. All rights reserved."], "FAU": ["Oliveira, Edinilze S C", "Pontes, Flavia L D", "Acho, Leonard D R", "do Rosario, Alessandro S", "da Silva, Barbara Janaina P", "de A Bezerra, Jaqueline", "Campos, Francinete R", "Lima, Emerson S", "Machado, Marcos B"], "AU": ["Oliveira ESC", "Pontes FLD", "Acho LDR", "do Rosario AS", "da Silva BJP", "de A Bezerra J", "Campos FR", "Lima ES", "Machado MB"], "AD": ["Nucleo de Estudos Quimicos de Micromoleculas da Amazonia - NEQUIMA, Instituto de Ciencias Exatas, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil.", "Departamento de Bioquimica e Biologia Molecular, Universidade Federal do Parana, Curitiba, Parana, Brazil.", "Laboratorio de Atividade Biologica, Faculdade de Ciencias Farmaceuticas, Universidade Federal do Amazonas Manaus, Amazonas, Brazil.", "Engenharia Florestal, Campus Paragominas, Universidade Federal Rural da Amazonia, Paragominas, Para, Brazil.", "Laboratorio de Atividade Biologica, Faculdade de Ciencias Farmaceuticas, Universidade Federal do Amazonas Manaus, Amazonas, Brazil.", "Nucleo de Estudos Quimicos de Micromoleculas da Amazonia - NEQUIMA, Instituto de Ciencias Exatas, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil; Departamento de Quimica, Ambiente e Alimentos, Instituto Federal de Educacao, Ciencia e Tecnologia do Amazonas, Manaus, Amazonas, Brazil.", "Nucleo de Estudos Quimicos de Micromoleculas da Amazonia - NEQUIMA, Instituto de Ciencias Exatas, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil; Departamento de Farmacia, Universidade Federal do Parana, Curitiba, Parana, Brazil.", "Laboratorio de Atividade Biologica, Faculdade de Ciencias Farmaceuticas, Universidade Federal do Amazonas Manaus, Amazonas, Brazil.", "Nucleo de Estudos Quimicos de Micromoleculas da Amazonia - NEQUIMA, Instituto de Ciencias Exatas, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil. Electronic address: marcosmachado@ufam.edu.br."], "LA": ["eng"], "PT": ["Journal Article"], "DEP": "20210428", "PL": "England", "TA": "J Pharm Biomed Anal", "JT": "Journal of pharmaceutical and biomedical analysis", "JID": "8309336", "SB": "IM", "OTO": ["NOTNLM"], "OT": ["ESI-HRMS", "Ellagitannin", "Enzymatic inhibition", "Flavonoid", "Myrcia sphaerocarpa", "PULCON"], "COIS": ["Declaration of Competing Interest The authors report no declarations of interest."], "EDAT": "2021/05/07 06:00", "MHDA": "2021/05/07 06:00", "CRDT": ["2021/05/06 20:34"], "PHST": ["2021/01/23 00:00 [received]", "2021/04/24 00:00 [revised]", "2021/04/26 00:00 [accepted]", "2021/05/06 20:34 [entrez]", "2021/05/07 06:00 [pubmed]", "2021/05/07 06:00 [medline]"], "AID": ["S0731-7085(21)00220-X [pii]", "10.1016/j.jpba.2021.114109 [doi]"], "PST": "aheadofprint", "SO": "J Pharm Biomed Anal. 2021 Apr 28;201:114109. doi: 10.1016/j.jpba.2021.114109."}